LENZ Therapeutics, Inc. (Nasdaq: LENZ) is a commercial-stage ophthalmic pharmaceutical company headquartered in San Diego, California, focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44% — the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia. LENZ commercializes VIZZ in the United States and establishes international licensing partnerships to provide access globally. The company publishes no developer program, public API, SDK, or machine-readable API description of any kind; its public surface is a ten-page WordPress marketing site, a VIZZ product site, and an investor-relations portal carrying SEC filings and a press-release RSS feed.
LENZ Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Life Sciences, and Healthcare.
LENZ Therapeutics’ developer surface includes engineering blog and 11 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: lenz-therapeutics
name: LENZ Therapeutics
description: 'LENZ Therapeutics, Inc. (Nasdaq: LENZ) is a commercial-stage ophthalmic pharmaceutical company headquartered
in San Diego, California, focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44% — the first and
only FDA-approved aceclidine-based eye drop for the treatment of presbyopia. LENZ commercializes VIZZ in the United States
and establishes international licensing partnerships to provide access globally. The company publishes no developer program,
public API, SDK, or machine-readable API description of any kind; its public surface is a ten-page WordPress marketing site,
a VIZZ product site, and an investor-relations portal carrying SEC filings and a press-release RSS feed.'
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://lenz-tx.com/wp-content/uploads/2022/06/gb_home_1200x630.jpg
url: https://raw.githubusercontent.com/api-evangelist/lenz-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-25'
modified: '2026-08-25'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Healthcare
- Ophthalmology
- Presbyopia
- Drug Development
- Public Company
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/lenz-therapeutics-domain-security.yml
- type: Website
url: https://lenz-tx.com/
- type: About
url: https://lenz-tx.com/about/
- type: Contact
url: https://lenz-tx.com/contact/
- type: Careers
url: https://lenz-tx.com/careers/
- type: TermsOfService
url: https://lenz-tx.com/terms-of-use/
- type: PrivacyPolicy
url: https://lenz-tx.com/privacy-policy/
- type: Blog
url: https://ir.lenz-tx.com/news-events/press-releases
- type: BlogRSS
url: https://ir.lenz-tx.com/news-events/press-releases/rss
- type: InvestorRelations
url: https://ir.lenz-tx.com/
- type: LinkedIn
url: https://www.linkedin.com/company/lenztx
- type: Twitter
url: https://twitter.com/lenz_tx
x-enrichment:
date: '2026-08-25'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: LENZ Therapeutics sells an FDA-approved eye drop, not software — its entire public estate is a ten-page WordPress
marketing site (lenz-tx.com), a VIZZ product site and an investor-relations portal, with no /developers, /api or /docs
page, no api./developer./docs. subdomain resolving in DNS, and no GitHub organization under any spelling of the name.
evidence:
- url: https://lenz-tx.com/developers
status: 404
- url: https://lenz-tx.com/openapi.json
status: 404
- url: https://api.lenz-tx.com/
status: 0
- url: https://api.github.com/orgs/lenz-tx
status: 404
- url: https://lenz-tx.com/page-sitemap.xml
status: 200
checked: '2026-08-25'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →